X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4299) 4299
Book Review (664) 664
Publication (127) 127
Book Chapter (56) 56
Conference Proceeding (24) 24
Book / eBook (8) 8
Dissertation (6) 6
Magazine Article (4) 4
Trade Publication Article (3) 3
Data Set (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3113) 3113
humans (2858) 2858
cardioversion (2708) 2708
atrial fibrillation (2623) 2623
cardiac & cardiovascular systems (2356) 2356
male (1911) 1911
female (1877) 1877
middle aged (1544) 1544
aged (1423) 1423
atrial fibrillation - therapy (1244) 1244
electrical cardioversion (1039) 1039
electric countershock (941) 941
atrial fibrillation - physiopathology (893) 893
sinus rhythm (843) 843
treatment outcome (827) 827
abridged index medicus (661) 661
electrocardiography (637) 637
anti-arrhythmia agents - therapeutic use (629) 629
atrial fibrillation - drug therapy (628) 628
adult (608) 608
fibrillation (571) 571
electric countershock - methods (556) 556
recurrence (553) 553
cardiac arrhythmia (478) 478
risk factors (476) 476
efficacy (468) 468
prospective studies (443) 443
catheter ablation (439) 439
transesophageal echocardiography (436) 436
stroke (415) 415
flutter (406) 406
defibrillation (396) 396
atrial fibrillation - diagnosis (394) 394
cardiology (385) 385
management (370) 370
time factors (366) 366
risk (364) 364
echocardiography (361) 361
atrial fibrillation - complications (356) 356
follow-up studies (348) 348
medicine, general & internal (343) 343
aged, 80 and over (335) 335
animals (334) 334
amiodarone (325) 325
anticoagulation (314) 314
maintenance (313) 313
cardiovascular (311) 311
care and treatment (306) 306
atrial fibrillation - diagnostic imaging (305) 305
therapy (303) 303
retrospective studies (272) 272
electric countershock - adverse effects (264) 264
prevention (262) 262
prognosis (257) 257
anticoagulants - therapeutic use (255) 255
arrhythmia (252) 252
peripheral vascular disease (251) 251
analysis (250) 250
ablation (249) 249
engineering, biomedical (249) 249
conversion (240) 240
atrial fibrillation - etiology (234) 234
echocardiography, transesophageal (232) 232
safety (231) 231
heart (229) 229
heart-failure (221) 221
arrhythmias (219) 219
mortality (216) 216
atrial fibrillation - epidemiology (214) 214
medicine & public health (214) 214
chronic disease (212) 212
atrial flutter (209) 209
predictive value of tests (201) 201
heart atria - physiopathology (199) 199
prevalence (199) 199
atrial fibrillation - surgery (198) 198
atrial fibrillation - blood (195) 195
atrial fibrillation - prevention & control (195) 195
atrial-fibrillation (195) 195
warfarin (191) 191
emergency medicine (182) 182
thromboembolism (180) 180
heart rate (179) 179
drug therapy (178) 178
rhythm control (177) 177
tachycardia (177) 177
anti-arrhythmia agents - administration & dosage (176) 176
c-reactive protein (176) 176
heart failure (176) 176
antiarrhythmic drugs (171) 171
anti-arrhythmia agents - adverse effects (169) 169
anticoagulants (166) 166
internal cardioversion (166) 166
defibrillators, implantable (161) 161
heart atria - diagnostic imaging (160) 160
inflammation (154) 154
follow-up (153) 153
amiodarone - therapeutic use (152) 152
dogs (149) 149
sensitivity and specificity (149) 149
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3865) 3865
German (210) 210
Spanish (91) 91
French (68) 68
Russian (51) 51
Polish (26) 26
Italian (20) 20
Korean (12) 12
Czech (9) 9
Japanese (8) 8
Turkish (8) 8
Portuguese (5) 5
Slovak (5) 5
Hungarian (4) 4
Lithuanian (3) 3
Persian (1) 1
Serbian (1) 1
Slovenian (1) 1
Ukrainian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


EUROPACE, ISSN 1099-5129, 05/2019, Volume 21, Issue 5, pp. 708 - 715
Aims Electrical cardioversion is commonly performed to restore sinus rhythm in patients with atrial fibrillation (AF), but it is unsuccessful in 10-12% of... 
POSTERIOR | Quality improvement | CARDIAC & CARDIOVASCULAR SYSTEMS | FORCE | Atrial fibrillation | IMPEDANCE | TRANSTHORACIC CARDIOVERSION | ELECTRODES | Cardioversion | Defibrillation | Protocol | EXTERNAL CARDIOVERSION
Journal Article
Journal of Cardiovascular Electrophysiology, ISSN 1045-3873, 09/2019, Volume 30, Issue 9, pp. 1764 - 1764
Journal Article
Journal Article
JOURNAL OF EMERGENCY MEDICINE, ISSN 0736-4679, 10/2018, Volume 55, Issue 4, pp. 571 - 571
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 11/2007, Volume 28, Issue 22, pp. 2803 - 2817
Journal Article
INTERNATIONAL JOURNAL OF CARDIOLOGY, ISSN 0167-5273, 02/2019, Volume 276, pp. 156 - 156
Journal Article
Heart Rhythm, ISSN 1547-5271, 01/2018, Volume 15, Issue 1, pp. 9 - 16
For patients with symptomatic, sustained atrial fibrillation (AF), a “pill-in-the-pocket” antiarrhythmic drug (PIP-AAD) strategy has been proposed to reduce... 
Antiarrhythmic | Cardioversion | Flecainide | Propafenone | Atrial fibrillation
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e531S - e575S
Background: The risk of stroke varies considerably across different groups of patients with atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is... 
DIRECT-CURRENT CARDIOVERSION | STROKE PREVENTION | RESPIRATORY SYSTEM | CLOPIDOGREL PLUS ASPIRIN | ORAL ANTICOAGULANT-THERAPY | RISK STRATIFICATION SCHEMES | MAJOR VASCULAR EVENTS | PULMONARY-VEIN ABLATION | ACUTE CORONARY SYNDROME | ECHOCARDIOGRAPHY-GUIDED CARDIOVERSION | ANTIARRHYTHMIC-DRUG THERAPY | CRITICAL CARE MEDICINE | Ticlopidine - therapeutic use | Humans | Electric Countershock | Hemorrhage - prevention & control | Dabigatran | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ticlopidine - adverse effects | Aspirin - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Benzimidazoles - therapeutic use | Stroke - prevention & control | beta-Alanine - adverse effects | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Atrial Fibrillation - complications | beta-Alanine - therapeutic use | Anticoagulants - therapeutic use | Hemorrhage - blood | Anticoagulants - adverse effects | Evidence-Based Medicine | Ticlopidine - analogs & derivatives | Atrial Fibrillation - blood | International Normalized Ratio | Stroke - blood | Atrial Flutter - complications | Atrial Flutter - drug therapy | Hemorrhage - chemically induced | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
The American Journal of Emergency Medicine, ISSN 0735-6757, 08/2019, pp. 158371 - 158371
CLINICAL QUESTIONValsalva maneuver is a recognized treatment for supraventricular tachycardia, but in clinical setting it has a low chance to achieve... 
Index Medicus
Journal Article
CIRCULATION, ISSN 0009-7322, 08/2006, Volume 114, Issue 7, pp. E257 - E354
Journal Article